Pierantoni Francesco

5PUBLICATIONS
44CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 24, 2026
Choriocarcinoma: Diagnosis, treatment and management of a rare germ cell tumour. An update review.

Pierantoni Francesco, Caliciotti Fabiana, Ahcene Djaballah Selma

|Jan 28, 2026
Long-Term Oncological Outcomes in Metastatic Prostate Cancer Patients Who Are Able to Maintain/Recover Ongoing Anticancer Therapy After SARS-CoV-2 Infection-Results of the MEET-URO 22 Study.

Orazio Caffo, Umberto Basso, Antonello Veccia

|Oct 13, 2025
Liquid Biopsy Identifies Taxane Resistance and Clonal Selection in Castration-Resistant Prostate Cancer.

Nicole Brighi, Daniel Wetterskog, Osvaldas Vainauskas

|Jul 24, 2023
Prognostic role of systemic inflammation indexes in metastatic urothelial carcinoma treated with immunotherapy.

Michele Dionese, Umberto Basso, Francesco Pierantoni

|Jan 21, 2023
Pembrolizumab Plus Axitinib for Metastatic Papillary and Chromophobe Renal Cell Carcinoma: NEMESIA (Non Clear MEtaStatic Renal Cell Carcinoma Pembrolizumab Axitinib) Study, a Subgroup Analysis of I-RARE Observational Study (Meet-URO 23a).

Marco Stellato, Sebastiano Buti, Marco Maruzzo

Pageof 1

Frequent Collaborators

4 joint publications

Umberto Basso

2 joint publications

Ugo De Giorgi

2 joint publications

Maria Giuseppa Vitale

2 joint publications

Brigida Anna Maiorano